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Abstract 
 
Multi-modal neuroimaging and biomarker data provide exciting opportunities to enhance our 
understanding of phenotypic characteristics associated with complex disorders. This study 
focuses on integrative analysis of structural MRI data and proteomic data from an RBM panel to 
examine their predictive power and identify relevant biomarkers in a large MCI/AD cohort. MRI 
data included volume and thickness measures of 98 regions estimated by FreeSurfer. RBM data 
included 146 proteomic analytes extracted from plasma and serum. A sparse learning model, 
elastic net logistic regression, was proposed to classify AD and MCI, and select disease-relevant 
biomarkers. A linear support vector machine coupled with feature selection was employed for 
comparison. Combining RBM and MRI data yielded improved prediction rates: HC vs AD 
(91.9%), HC vs MCI (90.5%) and MCI vs AD (86.5%). Elastic net identified a small set of 
meaningful imaging and proteomic biomarkers. The elastic net has great power to optimize the 
sparsity of feature selection while maintaining high predictive power. Its application to multi-
modal imaging and biomarker data has considerable potential for discovering biomarkers and 
enhancing mechanistic understanding of AD and MCI. 
 
